Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and Companion Animal Products
Increases Zoetis' range of products, with potential for greater global expansion
Provides future growth opportunities, manufacturing capacity, and insights into Australian animal health market
Strengthens Zoetis' anaesthetic portfolio with addition of Alfaxan®, a leading anaesthetic for companion animals
Zoetis Inc. (NYSE:ZTS) today announced it has completed the acquisition of Jurox, a privately held animal health company that develops, manufactures and markets a wide range of veterinary medicines for treating livestock and companion animals. Jurox's operations are based in Australia, with additional regional offices in New Zealand, U.S., Canada and the UK. Financial terms of the tr
